Ki-67 Is an Independent Predictor of Metastasis and Cause-Specific Mortality for Prostate Cancer Patients Treated on Radiation Therapy Oncology Group (RTOG) 94-08-Reference-Cited by-同舟云学术

Ki-67 Is an Independent Predictor of Metastasis and Cause-Specific Mortality for Prostate Cancer Patients Treated on Radiation Therapy Oncology Group (RTOG) 94-08

Published:2013-06 Issue:2 Volume:86 Page:317-323
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Verhoven Bret,Yan Yan,Ritter Mark,Khor Li-Yan,Hammond Elizabeth,Jones Christopher,Amin Mahul,Bahary Jean-Paul,Zeitzer Kenneth,Pollack Alan

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference19 articles.

1. Predictive models in external beam radiotherapy for clinically localized prostate cancer;Roach;Cancer,2009

2. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N Engl J Med,2011

3. COX-2 expression predicts prostate-cancer outcome: Analysis of data from the RTOG 92-02 trial;Khor;Lancet Oncol,2007

4. Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on Radiation Therapy Oncology Group protocol 92-02;Khor;Clin Cancer Res,2007

5. Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: An analysis of patients in Radiation Therapy Oncology Group protocol 86-10;Li;Clin Cancer Res,2004

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating Ras homolog gene family member C (RhoC) and Ki67 expression following external beam radiation therapy show increased RhoC expression in relapsing prostate cancer xenografts;Biochemical and Biophysical Research Communications;2024-10

2. The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach;Journal of Gastrointestinal Cancer;2024-02-27

3. Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation;eBioMedicine;2023-02

4. Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine;Journal of Personalized Medicine;2021-07-15

5. Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer;Cancers;2021-02-05